Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;6(3):e001323.
doi: 10.1136/rmdopen-2020-001323.

Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline

Serena Bugatti  1   2 , Ludovico De Stefano  3   2 , Francesca Bobbio-Pallavicini  3 , Carlomaurizio Montecucco  3   2
Affiliations

Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline

Serena Bugatti et al. RMD Open. 2020 Oct.
No abstract available

Keywords: Arthritis; Hydroxychloroquine; Lupus Erythematosus; Rheumatoid; Systemic.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;71:732–9. 10.1093/cid/ciaa237 - DOI - PMC - PubMed
    1. Liu J, Cao R, Xu M, et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov 2020;6:16 10.1038/s41421-020-0156-0 - DOI - PMC - PubMed
    1. Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 2020;16:155–66. 10.1038/s41584-020-0372-x - DOI - PubMed
    1. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘cytokine storm’ in COVID-19. J Infect 2020;80:607–13. 10.1016/j.jinf.2020.03.037 - DOI - PMC - PubMed
    1. Schreiber K, Breen K, Parmar K, et al. The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies. Rheumatology 2018;57:120–4. 10.1093/rheumatology/kex378 - DOI - PubMed

MeSH terms

LinkOut - more resources